Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2
We describe a physics-based learning model for predicting the immunogenicity of Cytotoxic-T-Lymphocyte (CTL) epitopes derived from diverse pathogens including SARS-CoV-2. The model was trained and optimized on the relative immunodominance of CTL epitopes in Human Immunodeficiency Virus infection. It...
Main Authors: | , , , , |
---|---|
Other Authors: | , , , , |
Format: | Article |
Language: | English |
Published: |
Elsevier BV,
2021-04-01T17:22:23Z.
|
Subjects: | |
Online Access: | Get fulltext |
Summary: | We describe a physics-based learning model for predicting the immunogenicity of Cytotoxic-T-Lymphocyte (CTL) epitopes derived from diverse pathogens including SARS-CoV-2. The model was trained and optimized on the relative immunodominance of CTL epitopes in Human Immunodeficiency Virus infection. Its accuracy was tested against experimental data from COVID-19 patients. Our model predicts that only some SARS-CoV-2 epitopes predicted to bind to HLA molecules are immunogenic. The immunogenic CTL epitopes across all SARS-CoV-2 proteins are predicted to provide broad population coverage, but those from the SARS-CoV-2 spike protein alone are unlikely to do so. Our model also predicts that several immunogenic SARS-CoV-2 CTL epitopes are identical to seasonal coronaviruses circulating in the population and such cross-reactive CD8+ T cells can indeed be detected in prepandemic blood donors, suggesting that some level of CTL immunity against COVID-19 may be present in some individuals prior to SARS-CoV-2 infection. National Science Foundation (U.S.) (Grant PHY-2026995) Frederick National Laboratory for Cancer Research (Contract HHSN261200800001E) National Institutes of Health (U.S.) (Grant AI138790) |
---|